loxoprofen has been researched along with Pneumonia, Viral in 1 studies
loxoprofen: RN given refers to parent cpd without isomeric designation; structure in first source
loxoprofen : A monocarboxylic acid that is propionic acid in which one of the hydrogens at position 2 is substituted by a 4-[(2-oxocyclopentyl)methyl]phenyl group. A prodrug that is rapidly converted into its active trans-alcohol metabolite following oral administration.
Pneumonia, Viral: Inflammation of the lung parenchyma that is caused by a viral infection.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sakaida, T | 1 |
| Tanimoto, I | 1 |
| Matsubara, A | 1 |
| Nakamura, M | 1 |
| Morita, A | 1 |
1 other study available for loxoprofen and Pneumonia, Viral
| Article | Year |
|---|---|
Unique skin manifestations of COVID-19: Is drug eruption specific to COVID-19?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Betacoronavirus; Cephalosporins; Coronavirus Infections; CO | 2020 |